Valuation : Terumo Corporation

Market Cap 3,642B 22.75B 19.63B 18.46B 16.82B 31.63B 2,159B 31.8B 218B 84.95B 1,098B 85.42B 83.57B P/E 2027 *
19.3x
P/E 2028 * 19.6x
Enterprise Value 3,688B 23.04B 19.87B 18.69B 17.03B 32.03B 2,187B 32.2B 221B 86.02B 1,112B 86.5B 84.62B EV / Sales 2027 *
2.93x
EV / Sales 2028 * 2.7x
Free-Float
97.07%
Yield 2027 *
1.46%
Yield 2028 * 1.6%
1 day-2.97%
1 week-4.91%
Current month-1.87%
1 month+6.24%
3 months+5.27%
6 months+17.01%
Current year+8.77%
1 week 2,450.5
Extreme 2450.5
2,588
1 month 2,255
Extreme 2255
2,689
Current year 1,900
Extreme 1900
2,689
1 year 1,900
Extreme 1900
2,696.5
3 years 1,856
Extreme 1856
3,182
5 years 1,708
Extreme 1708
3,182
10 years 955
Extreme 955
3,182
Manager TitleAgeSince
Chief Executive Officer 62 31/03/2024
Director of Finance/CFO - -
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman 68 31/03/2022
Director/Board Member 63 20/06/2019
Director/Board Member 75 24/06/2020
Change 5-day change 1-year change 3-year change Capi.($)
-2.97%-4.91%-7.98%+11.64% 23.45B
+2.56%-2.12%-15.05%+10.71% 188B
+1.52%+1.81%+0.39%+16.82% 118B
+1.61%+2.63%+14.10%+94.61% 63.16B
-1.89%-2.30%+26.76%+50.42% 52.01B
+1.56%-0.01%+1.09%-30.30% 50.97B
-0.02%+1.54%+21.57%-9.97% 34.02B
+1.38%+3.85% - - 30.8B
+1.07%-1.93%+40.79%-14.99% 23.83B
+2.23%-1.14%-3.28%+4.67% 22.39B
Average +0.68%-1.78%+8.71%+14.84% 60.69B
Weighted average by Cap. +1.28%-2.62%+1.72%+18.63%

Financials

2027 *2028 *
Net sales 1,258B 7.86B 6.78B 6.37B 5.81B 10.92B 746B 10.98B 75.36B 29.33B 379B 29.49B 28.86B 1,338B 8.36B 7.21B 6.78B 6.18B 11.62B 793B 11.68B 80.16B 31.2B 403B 31.37B 30.69B
Net income 192B 1.2B 1.03B 973M 886M 1.67B 114B 1.68B 11.5B 4.48B 57.89B 4.5B 4.4B 192B 1.2B 1.03B 972M 885M 1.66B 114B 1.67B 11.49B 4.47B 57.82B 4.5B 4.4B
Net Debt 45.99B 287M 248M 233M 212M 399M 27.27B 402M 2.76B 1.07B 13.87B 1.08B 1.06B -26.39B -165M -142M -134M -122M -229M -15.65B -230M -1.58B -616M -7.96B -619M -606M
Logo Terumo Corporation
Terumo Corp is a Japan-based company mainly engaged in the manufacture and sale of medical devices and pharmaceuticals. The Company operates in three segments. The Cardiovascular Company segment provides guidewires for angiography, catheters for angiography, introducer sheaths, coils, stents and bag embolization devices for treatment of cerebral aneurysms, artificial lungs and artificial heart-lung machines. The Medical Care Solutions Company segment provides hospital care solutions, life care solutions, and pharmaceutical solutions. The Blood and Cell Technology Company segment provides blood bags, component blood collection systems, automated blood product systems, pathogen reduction systems, and centrifugal blood component separators.
Employees
30,591
Date Price Change Volume
02/09/26 JP¥2,469.00 -2.97% 4,819,400
01/09/26 JP¥2,544.50 +1.13% 2,819,800
31/08/26 JP¥2,516.00 -0.91% 5,581,400
28/08/26 JP¥2,539.00 -0.82% 3,795,800
27/08/26 JP¥2,560.00 -0.47% 2,949,800
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
14
Last Close Price
2,469.00JPY
Average target price
3,133.08JPY
Spread / Average Target
+26.90%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 4543 Stock